| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/08/2006 | WO2006092893A1 Enterokinesis promoting compound |
| 09/08/2006 | WO2006092490A1 Diosmetin derivatives for the treatment and prevention of thrombotic pathologies |
| 09/08/2006 | WO2006092294A1 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof |
| 09/08/2006 | WO2006076575A3 Substituted biaryl compounds as factor xia inhibitors |
| 09/08/2006 | WO2006064373A3 Methods of purifying immunologlobulins |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599808A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/08/2006 | CA2599712A1 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof |
| 09/08/2006 | CA2599658A1 Diosmetin derivatives for the treatment and prevention of thrombotic pathologies |
| 09/07/2006 | US20060199818 Inhibiting the activity of a 5-hydroxytryptamine 2A by administering a N-heterocyclyl (preferably 1,3-dioxan-5-yl)-4-[(N-substituted)(hetero)arylamino]piperidine in which the N-substituant is arylalkanoyl, arylthioalkanoyl, arylalkylaminocarbonyl or arylalkylaminothiocarbonyl group |
| 09/07/2006 | US20060199794 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension |
| 09/07/2006 | US20060199787 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/07/2006 | US20060199766 Pharmaceutical composition comprising a factor VIIa and a factor XIII |
| 09/07/2006 | DE102005008649A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verwendung als Arzneimittel New substituted pyrrolidinones, their preparation and their use as medicaments |
| 09/06/2006 | EP1698626A1 Amidopyrazole derivative |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698340A1 T-type calcium channel inhibitor |
| 09/06/2006 | EP1698339A1 Neutrophilia inhibitor |
| 09/06/2006 | EP1697323A1 New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin |
| 09/06/2006 | EP1697318A1 Prolinylarylacetamides |
| 09/06/2006 | EP1696940A1 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma |
| 09/06/2006 | EP1423357B1 Urea derivatives with antiproteolytic activity |
| 09/06/2006 | EP1409490B1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a|naphthalenyl derivatives with antipsychotic activity |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP0832232B9 Kunitz type plasma kallikrein inhibitors |
| 09/06/2006 | CN1827766A In vitro cell cultivation method |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/06/2006 | CN1827635A Glycopeptide compositions |
| 09/06/2006 | CN1827616A Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole |
| 09/06/2006 | CN1827124A Dripping pills of herba lamiophlomis rotatae and method for preparing the same |
| 09/06/2006 | CN1827101A Hemostatic injection of carbazochrome sodium sulfonate and method for preparing the same |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/05/2006 | USRE39267 Thienopyrimidine-based inhibitors of the SRC family |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101903 9-(4-Methylbenzyl)-6-[4-(trifluoromethoxy)phenyl]-1,9-dihydropyrano[3,4-b]indole-3,4-dione; treating fibrinolytic disorders, vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101862 Hemostatic compositions and methods for controlling bleeding |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101846 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 09/05/2006 | US7101574 Pharmaceutical composition containing fenofibrate and the preparation method |
| 09/05/2006 | US7101557 Promoting coagulation in prothrombotic blood vessels, treating a vascularized tumor with a coagulation-deficient tissue factor compound |
| 09/05/2006 | US7101539 Increasing hematopoietic progenitor cells in a mammal by adminstering an interleukin-like polypeptide |
| 09/05/2006 | US7101519 Zirconium basic carbonate and methods of making the same |
| 08/31/2006 | WO2006090759A1 Pharmaceutical agent comprising solifenacin |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090616A1 Fat cell differentiation regulator |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006089952A1 Amidino-compounds por stabilizing factor vii polypeptide formulations |
| 08/31/2006 | WO2006089909A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 08/31/2006 | WO2006089478A1 The use of isoscutellarin for the manufacture of medicine |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194844 2-Acylaminothiazole derivative or salt thereof |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194795 Platelet ADP receptor inhibitors |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194727 Prevention and reduction of blood loss |
| 08/31/2006 | US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193826 Methods to mobilize progenitor/stem cells |
| 08/31/2006 | DE19952957B4 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 08/31/2006 | CA2599021A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 08/31/2006 | CA2598289A1 Tropoelastin for promoting endothelial cell adhesion or migration |
| 08/31/2006 | CA2594763A1 Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1695975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/30/2006 | EP1695962A1 Cyclic amine derivative having heteroaryl ring |
| 08/30/2006 | EP1695961A1 Urea derivative, process for producing the same, and use |
| 08/30/2006 | EP1695722A1 Collagen hemostatic foam |
| 08/30/2006 | EP1695698A1 Anti-angiogene compositions and methods of use |
| 08/30/2006 | EP1695697A1 Anti-angiogenic compositions and methods of use |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1505966A4 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 08/30/2006 | EP1490056B1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 08/30/2006 | EP1317429B1 Amidine inhibitors of serine proteases |
| 08/30/2006 | EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1826136A Compositions comprising factor ó° and factor IXa for treating haemophilia |
| 08/30/2006 | CN1826134A Pharmaceutical combination of G-CSF and PLGF useful for blood stem cell |
| 08/30/2006 | CN1826125A Method of replenishing cells damaged by treatment for cancer |
| 08/30/2006 | CN1824647A Crystal of (+-)2-(dimethylamino)-1-{[o-(m-methoxyphenethyl)phenoxy]methyl}ethyl hydrogen succinate hydrochloride |
| 08/30/2006 | CN1824311A Preparation for the prophylaxis of restenosis |
| 08/30/2006 | CN1824295A Preparation technology of poly gelatin peptide injection liquid |
| 08/30/2006 | CN1824260A Medicine for treating disease due to kidney yang vacuity |
| 08/30/2006 | CN1824241A Medicinal preparation and its new preparation method |
| 08/30/2006 | CN1824191A Medicine and food dual purpose Chinese medicine for blood stanching and its manufacturing method |